CHELSEA POWELL: Open Payments
NPI 1487248837 · FORSYTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$823 in 47 payments from 12 companies in 2025. Trend: 2023 $896 · 2024 $690 · 2025 $823
Food & beverage: $823
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $190 |
| AstraZeneca Pharmaceuticals LP | 7 | $139 |
| Lilly USA, LLC | 7 | $132 |
| Abbott Laboratories | 4 | $79 |
| Novo Nordisk Inc | 4 | $64 |
| PFIZER INC. | 3 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
| Pharming Healthcare, Inc. | 2 | $36 |
| Amgen Inc. | 2 | $27 |
| Antares Pharma, Inc. | 1 | $17 |
Products named: VRAYLAR, MOUNJARO, AIRSUPRA, FREESTYLE LIBRE 3, JARDIANCE, FARXIGA, PREVNAR 20, Ozempic.
Industry payments across GA — which companies pay providers there.
